Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
about
Receptor tyrosine kinases in the nucleusProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerDesigning nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivoInhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeuticsInhibition of cell proliferation by an anti-EGFR aptamerEGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.MUC1 regulates nuclear localization and function of the epidermal growth factor receptor.EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity.Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling.Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma.Autocrine-controlled formation and function of tissue-like aggregates by primary hepatocytes in micropatterned hydrogel arrays.Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locationsProteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor familyA fully human anti-CD47 blocking antibody with therapeutic potential for cancerNuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications.Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications.Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.Nuclear EGFR as a molecular target in cancer.The Mysterious Ways of ErbB2/HER2 TraffickingSym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers.Cetuximab treatment alters the content of extracellular vesicles released from tumor cells.Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro.¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.Sec61β facilitates the maintenance of endoplasmic reticulum homeostasis by associating microtubules.Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation.
P2860
Q26830216-AF872687-3B9B-44BC-835C-137963654B12Q26852215-CDEB716F-B780-4E7A-A602-313D673B1146Q28084216-B5729A5D-2B24-4C62-B225-07ECFB09C1D3Q28478752-B17E346C-4820-4C09-B35D-3CA086C489E8Q28487715-0B4D1062-BAB1-4278-A128-E0FD2F7E602DQ28743866-EC0832B6-23EC-4E9A-B6C1-9BDF2FEA67EFQ30456087-99F0EB28-AB1E-4AF6-86FC-30761709FD67Q33554130-4FEC5FA9-28B3-4F41-B0A8-3A6812A5AD36Q33830304-171C8D87-62CD-49A1-8D5B-C64FD69BA8A4Q33872371-C894D308-68CF-4317-8D39-68BE45EFA7FBQ34093260-1C0BA781-E5DD-431F-905F-766673A0565CQ34093266-DAF9D494-619A-4136-B514-8600DA8810A3Q34283213-1BFBC55D-5253-4253-A6E1-4D673D4C405EQ34715326-BD26CACA-8D78-4900-A751-5BE79CDA05AEQ35001415-8366F4C0-793E-4608-91AB-8F667902F553Q35831012-E0DC134B-2CED-41BC-B174-D1E01CA5476CQ36113481-50D9228F-B493-4A0D-8074-5F0A6ED42595Q36162605-5CBFC790-DED2-42C5-8E6B-28EB1D0F2E2CQ36198093-8FFABF23-E7C8-4BA3-8219-EE499E90B4ECQ36617162-CEB80E29-6F90-4CD3-A378-57B7D97F01CDQ36729566-B17E131E-C064-4F06-9268-7706575EFEB5Q36798851-DE799829-8E52-49AA-8D5B-6F0F881D198FQ36947703-01562063-E8D6-4C86-9C8D-32B140CF85A8Q37432540-23D413EB-813B-424D-95EA-9E68C9EBBBADQ37676970-0E9A395D-C494-4EF8-BCD6-4C00A5A87577Q38119635-06ED53FD-1F41-4B03-9E28-C53CB357702CQ38237727-FD4494FE-EB8C-4AF5-98D7-4379962632BAQ38369955-7A4D284B-211E-42E5-876A-FEFDE0DD82A3Q38782738-423B3A82-1AB1-4D77-B7E5-740DE5480599Q38955008-3983A021-F62A-46F6-B179-58027537C8AAQ39300555-02848059-131F-4362-ADA1-71FC66992E25Q39324549-4DB84E85-1EEE-4972-B26B-7F7A76DB1797Q42382736-6F1A7500-EE15-4550-81D7-1B6DB1FCF2E6Q46488616-BCCB93F7-F12F-4CAF-AFF5-FADE5EE5A2B6Q50697137-E8018C6B-C536-44BF-A033-84B3E8D0E524
P2860
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@ast
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en-gb
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@nl
type
label
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@ast
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en-gb
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@nl
prefLabel
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@ast
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en-gb
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@nl
P2860
P921
P1433
P1476
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor
@en
P2093
Graham Carpenter
Hong-Jun Liao
P2860
P304
P356
10.1158/0008-5472.CAN-09-0049
P407
P577
2009-08-01T00:00:00Z